Showing results (381-390 of 483) with videos related to

Sort By:
Pageof 49
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A ( F13A1 ): Decreased Platelet-Megakaryocyte F13A1 Expression and Clot Contraction in RUNX1 HaplodeficiencyFabiola Del Carpio-Cano, Natthapol Songdej, Liying Guan, et al.
Biomaterials|May 8, 2021
Platelet heterogeneity enhances blood clot volumetric contraction: An example of asynchrono-mechanical amplificationYueyi Sun, David R Myers, Svetoslav V Nikolov, et al.
Nature Communications|August 31, 2019
Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer's diseasePooja Jadiya, Devin W Kolmetzky, Dhanendra Tomar, et al.
Research and Practice in Thrombosis and Haemostasis|February 25, 2025
Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiencyFabiola Del Carpio-Cano, Natthapol Songdej, Liying Guan, et al.
Platelets|December 15, 2023
A case-control study of bleeding risk in children with 22q11.2 deletion syndrome undergoing cardiac surgeryT Blaine Crowley, Ian Campbell, Abinaya Arulselvan, et al.
Therapeutic Advances in Hematology|October 23, 2023
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III studyDavid J Kuter, James B Bussel, Waleed Ghanima, et al.
The Journal of Craniofacial Surgery|December 30, 2021
Thromboelastography Changes of Whole Blood Compared to Blood Component Transfusion in Infant Craniosynostosis SurgeryOlivia Nelson, Lezhou Wu, Jordan W Swanson, et al.
British Journal of Haematology|July 21, 2026
Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trialRachael F Grace, Göksel Leblebisatan, Yesim Aydinok, et al.
Journal of Neurochemistry|November 10, 2001
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodiesM P Lambert, K L Viola, B A Chromy, et al.
Blood Advances|March 31, 2018
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopeniaElizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski, et al.
Pageof 49